B. Kassler Taub - 28 Feb 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, Regulatory & QA
Signature
/s/ Kenneth B. Kassler-Taub, M.D.
Issuer symbol
LXRX
Transactions as of
28 Feb 2024
Net transactions value
-$63,805
Form type
4
Filing time
29 Feb 2024, 16:29:48 UTC
Previous filing
12 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +7,087 +5.9% 126,712 28 Feb 2024 Direct F1
transaction LXRX Common Stock Options Exercise +27,556 +22% 154,268 28 Feb 2024 Direct F1
transaction LXRX Common Stock Options Exercise +32,757 +21% 187,025 28 Feb 2024 Direct F1
transaction LXRX Common Stock Tax liability $63,805 -24,353 -13% $2.62 162,672 28 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -7,087 -100% 0 28 Feb 2024 Common Stock 7,087 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -27,556 -50% 27,557 28 Feb 2024 Common Stock 27,556 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -32,757 -33% 65,513 28 Feb 2024 Common Stock 32,757 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.